Sevelamer tablet in pharma franchise in Maharashtra

Sevelamer tablet in PCD pharma franchise in Chennai

Sevelamer tablet in top pharma company in Surat

Sevelamer tablet in pcd pharma supplier in Maharashtra

Sevelamer tablet in phama franchise company in india
Sevelamer tablet in phama distributor in Dehradun

Home/Products /sevelamer-400mg-tablet

Sevmoxl C 400 Tablet

Composition : Sevelamer (400mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Strip

Packaging : 10*10

Price : ₹329/-

Sevtyle C 400 Tablet contains Sevelamer (400mg), a phosphate binder used to control high phosphate levels in patients with chronic kidney disease (CKD) on dialysis. It works by binding to dietary phosphate in the digestive tract, preventing its absorption into the bloodstream, and helping to maintain normal phosphate levels. Proper phosphate control is crucial in preventing bone disorders, heart disease, and other complications associated with kidney disease.

Sevtyle C 400 is an essential medication for individuals undergoing hemodialysis or peritoneal dialysis, as it helps to reduce the risk of calcification in blood vessels and soft tissues. By lowering phosphate levels, it supports bone health and reduces complications related to kidney dysfunction.

  • Effective Phosphate Control: Prevents excess phosphate absorption, reducing complications in patients with CKD.

  • Supports Bone Health: Helps prevent renal osteodystrophy (bone disease caused by kidney failure).

  • Protects Cardiovascular Health: Reduces vascular calcification and associated heart problems.

  • Non-Absorbable & Well-Tolerated: Acts locally in the gut, minimizing systemic side effects.

  • Suitable for Dialysis Patients: Specifically formulated for individuals with kidney failure on dialysis.

Sevtyle C 400 is an important medication in nephrology, ensuring better management of chronic kidney disease and improving patients' overall well-being.

Read More

About the Product

Sevtyle C 400 Tablet contains Sevelamer (400mg), a phosphate binder used to control high phosphate levels in patients with chronic kidney disease (CKD) on dialysis. It works by binding to dietary phosphate in the digestive tract, preventing its absorption into the bloodstream, and helping to maintain normal phosphate levels. Proper phosphate control is crucial in preventing bone disorders, heart disease, and other complications associated with kidney disease.

Sevtyle C 400 is an essential medication for individuals undergoing hemodialysis or peritoneal dialysis, as it helps to reduce the risk of calcification in blood vessels and soft tissues. By lowering phosphate levels, it supports bone health and reduces complications related to kidney dysfunction.

  • Effective Phosphate Control: Prevents excess phosphate absorption, reducing complications in patients with CKD.

  • Supports Bone Health: Helps prevent renal osteodystrophy (bone disease caused by kidney failure).

  • Protects Cardiovascular Health: Reduces vascular calcification and associated heart problems.

  • Non-Absorbable & Well-Tolerated: Acts locally in the gut, minimizing systemic side effects.

  • Suitable for Dialysis Patients: Specifically formulated for individuals with kidney failure on dialysis.

Sevtyle C 400 is an important medication in nephrology, ensuring better management of chronic kidney disease and improving patients' overall well-being.

Common side effects include nausea, bloating, constipation, diarrhea, and stomach pain. Seek medical attention if symptoms persist or worsen.

Sevtyle C 400 Tablet is indicated for hyperphosphatemia (high phosphate levels) in patients with chronic kidney disease on dialysis.

This medication should be taken only under medical supervision. Regular monitoring of blood glucose levels, kidney function, and heart health is recommended. Patients with a history of heart disease, liver disorders, or bladder cancer should consult their doctor before use.

Store in a cool, dry place away from direct heat and moisture. Keep the bottle tightly closed after use.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation